stockrowCanopy Growth Corporation (CGC) vs Emergent Biosolutions Inc. (EBS)
- Canopy Growth Corporation CGC 0.68 −9.33%
- Emergent Biosolutions Inc. EBS 5.92 +0.34%
Canopy Growth Corporation and Emergent Biosolutions Inc. are both Drug Manufacturers Specialty & Generic companies. Canopy Growth Corporation and Emergent Biosolutions Inc. are of similar size ($300.8M and $283.5M). Canopy Growth Corporation grew revenue faster over the last twelve months: 7.80% against −17.7%. Emergent Biosolutions Inc. has the higher net margin (−40.2% vs −80.4%) and the lower return on invested capital (−17.5% vs −17.2%). Across the 19 metrics below, Emergent Biosolutions Inc. leads on 10 and Canopy Growth Corporation on 9.
Valuation
Profitability
| Metric | CGC | EBS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 25.16% | 48.42% | 53.51% |
| Operating margin | (54.89%) | (27.70%) | 0.00% |
| Net margin | (80.39%) | (40.16%) | (2.45%) |
| Free cash flow margin | (28.34%) | 29.89% | 0.00% |
| Return on equity | (40.14%) | (58.21%) | (0.80%) |
| Return on assets | (23.54%) | (21.23%) | (1.67%) |
| Return on invested capital | (17.19%) | (17.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack